Ducray Keracnyl PP+ Anti-Blemish Cream

Ducray Keracnyl PP+ Anti-Blemish Cream is a dermatologist-recommended treatment formulated to reduce inflamed pimples, soothe irritation, and limit post-acne marks.
Clinically proven to promote pimple reduction in just 7 days, it provides 24-hour hydration while compensating for dryness and flaking caused by acne treatments.
Enriched with exclusive actives like Myrtacine® and Celastrol, combined with Vitamin PP, this lightweight, non-greasy cream rebalances skin, reduces redness, and restores comfort.
Perfect for teenagers and adults (12+), it helps smooth the complexion and prevent new marks from forming.

• Myrtacine®: Exclusive ingredient that limits C.acnes bacteria biofilm, smoothing skin.
• Celastrol: 100% natural, produced by plant cell culture, with a soothing effect to calm inflamed spots.
• Vitamin PP: Reduces redness and irritation, providing comfort.
• Monolaurin: Offers a mattifying action by reducing sebum.

FAQs

Q1. How does Ducray Keracnyl PP+ achieve visible pimple reduction in 7 days?
A1. The formula combines four targeted actives: Myrtacine® — Ducray's exclusive active that specifically inhibits the biofilm formed by C.acnes bacteria (the bacterial structure that makes breakouts persistent), disrupting bacterial colonisation rather than just killing surface bacteria; Celastrol, a natural compound produced by plant cell culture with powerful anti-inflammatory action on inflamed spots; Vitamin PP (Niacinamide) which rapidly reduces the redness, irritation, and post-blemish skin discomfort; and Monolaurin, which provides antimicrobial sebum regulation. The 7-day claim specifically refers to measurable reduction in pimple count and redness in clinical testing with consistent twice-daily use.

Q2. Can it be used as the sole moisturizer for acne-prone skin during a prescription treatment course?
A2. Yes — it's designed to serve as the moisturizing step in a medical acne treatment routine, not as an addition to a complex skincare stack. When on Roaccutane, topical antibiotics, or prescription retinoids (all of which cause dryness and irritation), Keracnyl PP+ manages the side effects — reducing dryness, redness, and flaking — while the prescription works on the acne itself. It's specifically designed as a tolerability partner for these treatments.

Q3. Is it suitable for teenage skin?
A3. Yes — it's tested for use from age 12+. The Celastrol and Myrtacine® combination is particularly relevant for the inflammatory acne common in adolescence; it reduces the discomfort and visible inflammation of active spots without the irritation that harsh acne treatments often cause on teen skin.

Q4. Does it have a matte finish suitable for school or office wear?
A4. Yes — Monolaurin regulates sebum output, and the cream absorbs to a matte, non-greasy finish appropriate for day wear. It can be applied before a non-comedogenic tinted SPF or BB cream for coverage. For all-day matte control, a setting powder over it helps maintain the finish in humid conditions.

Q5. How does it help with the marks acne leaves behind?
A5. Vitamin PP (Niacinamide) reduces post-inflammatory redness immediately and supports the gradual fading of PIH (post-inflammatory hyperpigmentation) over weeks of consistent use. Myrtacine® reduces the bacterial recurrence that triggers new spots in the same areas. For deeper brown marks, adding a dedicated niacinamide or azelaic acid serum and daily SPF 50+ PA+++ to your routine significantly accelerates pigmentation fading.

Country of Origin: France
Mfg/Marketer details: Pierre Fabre Dermo-Cosmétique, Usine De Soual, Route De Cambounet, Soual, 81580, France
Importer details: A. Menarini India Private Limited, A-101, 2102, Tower 3, One International Center, Senapati Bapat Marg, Elphinstone Road (W), Mumbai, Maharashtra - 400013, India
Shelf Life: 36 months from manufacturing date
Storage: Store in a cool, dry place away from direct sunlight
Safety Information: For external use only. Avoid contact with eyes. In case of contact, rinse thoroughly with water. Keep out of reach of children.